Financial Report
1 January - 31 December
|
kEUR |
Note |
2022 |
2021 |
|
|
|
|
|
|
Result for the year |
|
7,767 |
47,258 |
|
|
|
|
|
|
Other comprehensive income to be reclassified to profit or loss in subsequent periods |
|
|
|
|
Exchange differences on translation of foreign operations, net of tax |
|
4,834 |
14,901 |
|
Net other comprehensive income to be reclassified to profit or loss in subsequent periods |
|
4,834 |
14,901 |
|
|
|
|
|
|
Other comprehensive income not to be reclassified to profit or loss in subsequent periods |
|
|
|
|
Remeasurement gain / (loss) on defined benefit plans |
|
13,526 |
1,187 |
|
Income tax effect |
5 |
-3,174 |
-354 |
|
Net other comprehensive income not to be reclassified to profit or loss in subsequent periods |
|
10,352 |
833 |
|
Other comprehensive result for the year, net of taxes |
|
15,186 |
15,734 |
|
|
|
|
|
|
Total comprehensive result for the year, net of taxes |
|
22,953 |
62,992 |
|
|
|
|
|
|
Attributable to shareholders of PolyPeptide Group AG |
|
22,953 |
62,992 |